X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare JUBILANT LIFE SCIENCES with ALEMBIC PHARMA - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

JUBILANT LIFE SCIENCES vs ALEMBIC PHARMA - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    JUBILANT LIFE SCIENCES ALEMBIC PHARMA JUBILANT LIFE SCIENCES/
ALEMBIC PHARMA
 
P/E (TTM) x 20.5 26.1 78.6% View Chart
P/BV x 4.4 6.0 73.2% View Chart
Dividend Yield % 0.4 0.8 52.7%  

Financials

 JUBILANT LIFE SCIENCES   ALEMBIC PHARMA
EQUITY SHARE DATA
    JUBILANT LIFE SCIENCES
Mar-14
ALEMBIC PHARMA
Mar-16
JUBILANT LIFE SCIENCES/
ALEMBIC PHARMA
5-Yr Chart
Click to enlarge
High Rs187792 23.6%   
Low Rs65443 14.7%   
Sales per share (Unadj.) Rs364.3167.0 218.1%  
Earnings per share (Unadj.) Rs6.838.2 17.9%  
Cash flow per share (Unadj.) Rs24.542.0 58.3%  
Dividends per share (Unadj.) Rs3.004.00 75.0%  
Dividend yield (eoy) %2.40.6 367.6%  
Book value per share (Unadj.) Rs164.984.9 194.2%  
Shares outstanding (eoy) m159.28188.52 84.5%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.33.7 9.4%   
Avg P/E ratio x18.416.2 113.7%  
P/CF ratio (eoy) x5.114.7 35.0%  
Price / Book Value ratio x0.87.3 10.5%  
Dividend payout %43.810.5 418.1%   
Avg Mkt Cap Rs m20,061116,383 17.2%   
No. of employees `0006.2NA-   
Total wages/salary Rs m11,0524,214 262.3%   
Avg. sales/employee Rs Th9,383.0NM-  
Avg. wages/employee Rs Th1,786.9NM-  
Avg. net profit/employee Rs Th176.3NM-  
INCOME DATA
Net Sales Rs m58,03431,487 184.3%  
Other income Rs m19155 345.9%   
Total revenues Rs m58,22431,542 184.6%   
Gross profit Rs m5,78610,060 57.5%  
Depreciation Rs m2,812722 389.4%   
Interest Rs m3,23737 8,796.7%   
Profit before tax Rs m-729,356 -0.8%   
Minority Interest Rs m-2860-   
Prior Period Items Rs m0-2 0.0%   
Extraordinary Inc (Exp) Rs m2,1450-   
Tax Rs m6962,160 32.2%   
Profit after tax Rs m1,0907,194 15.2%  
Gross profit margin %10.031.9 31.2%  
Effective tax rate %-965.923.1 -4,183.3%   
Net profit margin %1.922.8 8.2%  
BALANCE SHEET DATA
Current assets Rs m29,28015,066 194.4%   
Current liabilities Rs m38,9127,674 507.0%   
Net working cap to sales %-16.623.5 -70.7%  
Current ratio x0.82.0 38.3%  
Inventory Days Days8467 126.0%  
Debtors Days Days5141 124.8%  
Net fixed assets Rs m55,7128,237 676.3%   
Share capital Rs m155377 41.0%   
"Free" reserves Rs m20,96815,416 136.0%   
Net worth Rs m26,26516,005 164.1%   
Long term debt Rs m17,1690-   
Total assets Rs m88,60624,594 360.3%  
Interest coverage x1.0255.2 0.4%   
Debt to equity ratio x0.70-  
Sales to assets ratio x0.71.3 51.2%   
Return on assets %4.929.4 16.6%  
Return on equity %4.244.9 9.2%  
Return on capital %11.658.7 19.7%  
Exports to sales %37.855.7 67.8%   
Imports to sales %16.510.4 158.1%   
Exports (fob) Rs m21,93317,551 125.0%   
Imports (cif) Rs m9,5673,283 291.4%   
Fx inflow Rs m22,00417,811 123.5%   
Fx outflow Rs m11,7495,318 220.9%   
Net fx Rs m10,25512,493 82.1%   
CASH FLOW
From Operations Rs m8,0269,304 86.3%  
From Investments Rs m-1,744-3,105 56.2%  
From Financial Activity Rs m-4,447-1,959 227.0%  
Net Cashflow Rs m1,8344,240 43.3%  

Share Holding

Indian Promoters % 45.6 74.1 61.5%  
Foreign collaborators % 3.5 0.0 -  
Indian inst/Mut Fund % 8.7 2.9 300.0%  
FIIs % 21.2 9.1 233.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 21.1 13.9 151.8%  
Shareholders   23,815 49,328 48.3%  
Pledged promoter(s) holding % 15.9 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare JUBILANT LIFE SCIENCES With:   J.B.CHEMICALS  SUVEN LIFE  CIPLA  CADILA HEALTHCARE  VENUS REMEDIES  

Compare JUBILANT LIFE SCIENCES With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes on a Strong Note; Bank & Realty Stocks Rally(Closing)

Indian share markets surged further in the afternoon session and finished in the green for the second straight session on heavy buying in realty stocks, metal stocks and bank stocks.

Related Views on News

Most Popular

This Small Cap Can Drive Chinese Players Out of India (and Make a Fortune in the Process)(The 5 Minute Wrapup)

Aug 17, 2017

A small-cap Indian company with high-return potential and blue-chip-like stability is set to supplant the Chinese players in this niche segment.

Dear PM Modi, India is Already Land of Self-Employed, and It Ain't Working(Vivek Kaul's Diary)

Aug 21, 2017

Most Indians who cannot find jobs, look at becoming self-employed.

It's the Best Time to Buy IT Stocks(Daily Profit Hunter)

Aug 16, 2017

The IT Sector could be in an uptrend till February 2019. Are you prepared to ride the trend?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

Think Twice Before You Keep Money In A Savings Bank Account(Outside View)

Aug 22, 2017

Post demonetisation, a cut in bank savings deposits rates was in the offing.

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

JUBILANT LIFE SCIENCES SHARE PRICE


Aug 23, 2017 (Close)

TRACK JUBILANT LIFE SCIENCES

  • Track your investment in JUBILANT LIFE SCIENCES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON JUBILANT LIFE SCIENCES

JUBILANT LIFE SCIENCES - FDC LTD. COMPARISON

COMPARE JUBILANT LIFE SCIENCES WITH

MARKET STATS